UMIN ID: UMIN000055582
Registered date:23/09/2024
Dual dopaminergic therapy for tic disorder and Tourette's syndrome
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | Tic disorders and Tourette's syndrome |
| Date of first enrollment | 2024/03/01 |
| Target sample size | 27 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Prescribe Wintamin and Dopacol for patients with chronic tic disorders who visited our hospital and evaluate their symptoms. |
Outcome(s)
| Primary Outcome | YGTSS and YBOCS |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 1years-old |
|---|---|
| Age maximum | 120years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Patients deemed ineligible by a physician |
Related Information
| Primary Sponsor | Osaka Neurological Institute |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Osaka Neurological Institute |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Masahira Kiyota |
| Address | 2-6-23 Shounai Takaramachi Toyonaka Osaka Japan 5610836 |
| Telephone | 0663330086 |
| kiyota@oni.or.jp | |
| Affiliation | Osaka Neurological Institute IRB |
| scientific contact | |
| Name | Shinnichi Matsumoto |
| Address | 2-6-23 Shounai Takaramachi Toyonaka Osaka Japan |
| Telephone | 0663330086 |
| dyt1mc@yahoo.co.jp | |
| Affiliation | Osaka Neurological institute Neurology |